Last 12 months
Inside the activity.
1 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 01, 2026 Filed Sep 4, 2026 11:56 UTC |
Veillon-Berteloot ChantalEVP & CHRO
|
Tax withholdingCommon Stock | 1,455 | $16.62 | $24,182.10 |
DisclosureSEC source: 0001990905-26-000004 · wk-form4_1788522975.xml · nonDerivative · entry 1 Veillon-Berteloot Chantal · CIK 0001990905 · EVP & CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,772 Read SEC document |
| July 03, 2026 Filed Jul 6, 2026 20:40 UTC |
Knight Lea DanielsEVP & Chief Financial Officer
|
Tax withholdingCommon Stock | 5,226 | $18.05 | $94,329.30 |
DisclosureSEC source: 0001983748-26-000003 · wk-form4_1783370404.xml · nonDerivative · entry 1 Knight Lea Daniels · CIK 0001983748 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,263 Read SEC document |
| July 01, 2026 Filed Jul 6, 2026 20:43 UTC |
Mosebrook JeffreySVP, Fin & Princ Acct Officer
|
Tax withholdingCommon Stock | 937 | $17.89 | $16,762.93 |
DisclosureSEC source: 0001719686-26-000003 · wk-form4_1783370616.xml · nonDerivative · entry 1 Mosebrook Jeffrey · CIK 0001719686 · SVP, Fin & Princ Acct Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,516 Read SEC document |
| July 01, 2026 Filed Jul 6, 2026 20:42 UTC |
Singh HarvinderEVP & President, SS
|
GrantRestricted Stock Units · Derivative | 5,590 | $0.00 | $0.00 |
DisclosureSEC source: 0001949782-26-000003 · wk-form4_1783370564.xml · derivative · entry 1 Singh Harvinder · CIK 0001949782 · EVP & President, SS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,883 Underlying: Common Stock · 5,590 shares Expires not disclosed F1 · derivative.exercise_price: Grant of restricted stock units ("RSUs") pursuant to the Integra LifeSciences Holdings Corporation Fifth Amended and Restated 2003 Equity Incentive Plan, as amended (the "Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: All RSUs reported in this row were granted under the Plan and will vest ratably in three equal annual installments on each of the first, second, and third anniversaries of the grant date, subject to the Reporting Person's continued service through each applicable vesting date. F2 · derivative.expiration_date: All RSUs reported in this row were granted under the Plan and will vest ratably in three equal annual installments on each of the first, second, and third anniversaries of the grant date, subject to the Reporting Person's continued service through each applicable vesting date. Read SEC document |
| July 01, 2026 Filed Jul 6, 2026 20:41 UTC |
DAVIS ROBERT T. JR.EVP & President, TR&DT
|
GrantRestricted Stock Units · Derivative | 11,180 | $0.00 | $0.00 |
DisclosureSEC source: 0001563606-26-000003 · wk-form4_1783370499.xml · derivative · entry 1 DAVIS ROBERT T. JR. · CIK 0001563606 · EVP & President, TR&DT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,530 Underlying: Common Stock · 11,180 shares Expires not disclosed F1 · derivative.exercise_price: Grant of restricted stock units ("RSUs") pursuant to the Integra LifeSciences Holdings Corporation Fifth Amended and Restated 2003 Equity Incentive Plan, as amended (the "Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: All RSUs reported in this row were granted under the Plan and will vest in full on the second anniversary of the grant date, subject to the Reporting Person's continued service through such date. F2 · derivative.expiration_date: All RSUs reported in this row were granted under the Plan and will vest in full on the second anniversary of the grant date, subject to the Reporting Person's continued service through such date. Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 20:58 UTC |
McBreen Michael J.EVP & Chief Commercial Officer
|
GrantRestricted Stock Units · Derivative | 31,909 | $0.00 | $0.00 |
DisclosureSEC source: 0001814943-26-000003 · wk-form4_1780520318.xml · derivative · entry 2 McBreen Michael J. · CIK 0001814943 · EVP & Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 124,017 Underlying: Common Stock · 31,909 shares Expires not disclosed F2 · derivative.exercise_price: Grant of restricted stock units ("RSUs") pursuant to the Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock. F3 · derivative.exercise_date: All RSUs reported in this row were granted under the Plan and will vest ratably in three equal annual installments on each of the first, second, and third anniversaries of the grant date, subject to the Reporting Person's continued service through each applicable vesting date. F3 · derivative.expiration_date: All RSUs reported in this row were granted under the Plan and will vest ratably in three equal annual installments on each of the first, second, and third anniversaries of the grant date, subject to the Reporting Person's continued service through each applicable vesting date. Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 20:58 UTC |
McBreen Michael J.EVP & Chief Commercial Officer
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 60,372 | $0.00 Strike: $15.67 | $0.00 |
DisclosureSEC source: 0001814943-26-000003 · wk-form4_1780520318.xml · derivative · entry 1 McBreen Michael J. · CIK 0001814943 · EVP & Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,372 Underlying: Common Stock · 60,372 shares Expires 2034-06-01 F1 · derivative.exercise_date: This award consists of stock options granted pursuant to the Integra LifeSciences Holdings Corporation Fifth Amended and Restated 2003 Equity Incentive Plan, as amended (the "Plan") and will vest ratably in three equal annual installments on each of the first, second, and third anniversaries of the grant date, in each case subject to the Reporting Person's continued service through the applicable vesting dates. Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 20:54 UTC |
ESSIG STUARTDirector · President and CEO
|
GrantRestricted Stock Units · Derivative | 365,297 | $0.00 | $0.00 |
DisclosureSEC source: 0001187574-26-000008 · wk-form4_1780520095.xml · derivative · entry 2 ESSIG STUART · CIK 0001187574 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 365,297 Underlying: Common Stock · 365,297 shares Expires not disclosed F2 · derivative.exercise_price: Grant of restricted stock units ("RSUs") pursuant to the Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock. F3 · derivative.exercise_date: This award consists of (x) 255,265 RSUs granted pursuant to the equity award provisions of the Employment Agreement, and (y) 110,032 RSUs granted at the discretion of the Compensation Committee. All RSUs reported in this row were granted under the Plan and will vest as to one-third of the shares on the first anniversary of 5/1/2026 and thereafter in monthly installments through the following twenty-four months, in each case subject to the Reporting Person's continued service through the applicable vesting dates. F3 · derivative.expiration_date: This award consists of (x) 255,265 RSUs granted pursuant to the equity award provisions of the Employment Agreement, and (y) 110,032 RSUs granted at the discretion of the Compensation Committee. All RSUs reported in this row were granted under the Plan and will vest as to one-third of the shares on the first anniversary of 5/1/2026 and thereafter in monthly installments through the following twenty-four months, in each case subject to the Reporting Person's continued service through the applicable vesting dates. Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 20:54 UTC |
ESSIG STUARTDirector · President and CEO
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 705,468 | $0.00 Strike: $15.67 | $0.00 |
DisclosureSEC source: 0001187574-26-000008 · wk-form4_1780520095.xml · derivative · entry 1 ESSIG STUART · CIK 0001187574 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 705,468 Underlying: Common Stock · 705,468 shares Expires 2034-06-01 F1 · derivative.exercise_date: This award consists of (x) 482,976 stock options granted pursuant to the equity award provisions of the Reporting Person's employment agreement with the Issuer (the "Employment Agreement"), and (y) 222,492 stock options granted at the discretion of the Compensation Committee of the Issuer's Board of Directors (the "Compensation Committee"). All stock options reported in this row were granted under the Integra LifeSciences Holdings Corporation Fifth Amended and Restated 2003 Equity Incentive Plan, as amended (the "Plan") and will vest as to one-third of such stock options on the first anniversary of 5/1/2026 and thereafter in monthly installments through the following twenty-four months, in each case subject to the Reporting Person's continued service through the applicable vesting dates. Read SEC document |
| May 09, 2026 Filed May 11, 2026 20:40 UTC |
BRADLEY KEITHDirector
|
Tax withholdingCommon Stock | 882 | $13.92 | $12,277.44 |
DisclosureSEC source: 0001188650-26-000001 · wk-form4_1778532047.xml · nonDerivative · entry 1 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 88,254 Read SEC document |
| May 07, 2026 Filed May 11, 2026 20:40 UTC |
BRADLEY KEITHDirector
|
GrantRestricted Stock Units · Derivative | 17,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001188650-26-000001 · wk-form4_1778532047.xml · derivative · entry 2 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,700 Underlying: Common Stock · 17,700 shares Expires not disclosed F1 · derivative.exercise_price: Grant of restricted stock units (RSUs) pursuant to the Integra LifeSciences Holdings Corporation (IART) Fifth Amended and Restated 2003 Equity Incentive Plan, as amended. Each RSU represents a contingent right to receive one share of IART common stock. F2 · derivative.exercise_date: RSUs vest in full on the one-year anniversary of the grant date of May 7, 2026. F2 · derivative.expiration_date: RSUs vest in full on the one-year anniversary of the grant date of May 7, 2026. Read SEC document |
| May 07, 2026 Filed May 11, 2026 20:41 UTC |
HILL BARBARA BDirector
|
GrantCommon Stock | 17,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001235676-26-000001 · wk-form4_1778532093.xml · nonDerivative · entry 2 HILL BARBARA B · CIK 0001235676 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 151,191 Read SEC document |
| May 07, 2026 Filed May 11, 2026 20:41 UTC |
HILL BARBARA BDirector
|
GrantCommon Stock | 6,638 | $0.00 | $0.00 |
DisclosureSEC source: 0001235676-26-000001 · wk-form4_1778532093.xml · nonDerivative · entry 1 HILL BARBARA B · CIK 0001235676 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 133,491 Read SEC document |
| May 07, 2026 Filed May 11, 2026 20:39 UTC |
Clay ShaundraDirector
|
GrantRestricted Stock Units · Derivative | 17,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001857606-26-000001 · wk-form4_1778531995.xml · derivative · entry 1 Clay Shaundra · CIK 0001857606 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,700 Underlying: Common Stock · 17,700 shares Expires not disclosed F1 · derivative.exercise_price: Grant of restricted stock units (RSUs) pursuant to the Integra LifeSciences Holdings Corporation (IART) Fifth Amended and Restated 2003 Equity Incentive Plan, as amended. Each RSU represents a contingent right to receive one share of IART common stock. F2 · derivative.exercise_date: RSUs vest in full on the one-year anniversary of the grant date of May 7, 2026. The reporting person elected to defer receipt of the shares underlying the RSUs. In accordance with her deferral election, vested shares will be delivered to the reporting person in one lump sum, in the calendar year next following the calendar year in which the reporting person's termination of service on the Board of Directors occurs (unless the reporting person elected a later calendar year). F2 · derivative.expiration_date: RSUs vest in full on the one-year anniversary of the grant date of May 7, 2026. The reporting person elected to defer receipt of the shares underlying the RSUs. In accordance with her deferral election, vested shares will be delivered to the reporting person in one lump sum, in the calendar year next following the calendar year in which the reporting person's termination of service on the Board of Directors occurs (unless the reporting person elected a later calendar year). Read SEC document |
| May 07, 2026 Filed May 11, 2026 20:38 UTC |
GRAVES JEFFREY ADirector
|
GrantRestricted Stock Units · Derivative | 17,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001251036-26-000011 · wk-form4_1778531929.xml · derivative · entry 1 GRAVES JEFFREY A · CIK 0001251036 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,700 Underlying: Common Stock · 17,700 shares Expires not disclosed F1 · derivative.exercise_price: Grant of restricted stock units (RSUs) pursuant to the Integra LifeSciences Holdings Corporation (IART) Fifth Amended and Restated 2003 Equity Incentive Plan, as amended. Each RSU represents a contingent right to receive one share of IART common stock. F2 · derivative.exercise_date: RSUs vest in full on the one-year anniversary of the grant date of May 7, 2026. F2 · derivative.expiration_date: RSUs vest in full on the one-year anniversary of the grant date of May 7, 2026. Read SEC document |
| May 07, 2026 Filed May 11, 2026 20:38 UTC |
Lo Renee WonlaiDirector
|
GrantRestricted Stock Units · Derivative | 17,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001939584-26-000001 · wk-form4_1778531885.xml · derivative · entry 1 Lo Renee Wonlai · CIK 0001939584 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,700 Underlying: Common Stock · 17,700 shares Expires not disclosed F1 · derivative.exercise_price: Grant of restricted stock units (RSUs) pursuant to the Integra LifeSciences Holdings Corporation (IART) Fifth Amended and Restated 2003 Equity Incentive Plan, as amended. Each RSU represents a contingent right to receive one share of IART common stock. F2 · derivative.exercise_date: RSUs vest in full on the one-year anniversary of the grant date of May 7, 2026. F2 · derivative.expiration_date: RSUs vest in full on the one-year anniversary of the grant date of May 7, 2026. Read SEC document |
| May 07, 2026 Filed May 11, 2026 20:37 UTC |
SCHADE CHRISTIAN SDirector
|
GrantRestricted Stock Units · Derivative | 17,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001214496-26-000001 · wk-form4_1778531820.xml · derivative · entry 1 SCHADE CHRISTIAN S · CIK 0001214496 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,700 Underlying: Common Stock · 17,700 shares Expires not disclosed F1 · derivative.exercise_price: Grant of restricted stock units (RSUs) pursuant to the Integra LifeSciences Holdings Corporation (IART) Fifth Amended and Restated 2003 Equity Incentive Plan, as amended. Each RSU represents a contingent right to receive one share of IART common stock. F2 · derivative.exercise_date: RSUs vest in full on the one-year anniversary of the grant date of May 7, 2026. The reporting person elected to defer receipt of the shares underlying the RSUs. In accordance with his deferral election, vested shares will be delivered to the reporting person in one lump sum, in the calendar year next following the calendar year in which the reporting person's termination of service on the Board of Directors occurs (unless the reporting person elected a later calendar year). F2 · derivative.expiration_date: RSUs vest in full on the one-year anniversary of the grant date of May 7, 2026. The reporting person elected to defer receipt of the shares underlying the RSUs. In accordance with his deferral election, vested shares will be delivered to the reporting person in one lump sum, in the calendar year next following the calendar year in which the reporting person's termination of service on the Board of Directors occurs (unless the reporting person elected a later calendar year). Read SEC document |
| March 11, 2026 Filed Mar 12, 2026 22:10 UTC |
Singh HarvinderEVP & PRESIDENT, INTERNATIONAL
|
GrantRestricted Stock Units · Derivative | 60,865 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001949782-26-000001 · wk-form4_1773353453.xml · derivative · entry 9 Singh Harvinder · CIK 0001949782 · EVP & PRESIDENT, INTERNATIONAL 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,293 Underlying: Common Stock · 60,865 shares Expires not disclosed F4 · derivative.exercise_date: The award was a restricted stock unit award which will vest 33% on the first and second anniversaries and 34% on the third anniversary of the grant date of 3/11/2026. F4 · derivative.expiration_date: The award was a restricted stock unit award which will vest 33% on the first and second anniversaries and 34% on the third anniversary of the grant date of 3/11/2026. Read SEC document |
| March 11, 2026 Filed Mar 12, 2026 22:10 UTC |
Singh HarvinderEVP & PRESIDENT, INTERNATIONAL
|
Exercise / conversionRestricted Stock Units · Derivative | 16,566 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001949782-26-000001 · wk-form4_1773353453.xml · derivative · entry 8 Singh Harvinder · CIK 0001949782 · EVP & PRESIDENT, INTERNATIONAL 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,428 Underlying: Common Stock · 16,566 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The award was a restricted stock unit award of which 100% vested on the second anniversary of the grant date of 3/11/2024 F3 · derivative.expiration_date: The award was a restricted stock unit award of which 100% vested on the second anniversary of the grant date of 3/11/2024 Read SEC document |
| March 11, 2026 Filed Mar 12, 2026 22:10 UTC |
Singh HarvinderEVP & PRESIDENT, INTERNATIONAL
|
Exercise / conversionRestricted Stock Units · Derivative | 2,356 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001949782-26-000001 · wk-form4_1773353453.xml · derivative · entry 7 Singh Harvinder · CIK 0001949782 · EVP & PRESIDENT, INTERNATIONAL 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,994 Underlying: Common Stock · 2,356 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The award was a restricted stock unit award of which 33% vested on the second anniversary of the grant date of 3/11/2024 F2 · derivative.expiration_date: The award was a restricted stock unit award of which 33% vested on the second anniversary of the grant date of 3/11/2024 Read SEC document |
| March 11, 2026 Filed Mar 12, 2026 22:10 UTC |
Singh HarvinderEVP & PRESIDENT, INTERNATIONAL
|
Tax withholdingCommon Stock | 5,190 | $9.61 | $49,875.90 |
DisclosureSEC source: 0001949782-26-000001 · wk-form4_1773353453.xml · nonDerivative · entry 5 Singh Harvinder · CIK 0001949782 · EVP & PRESIDENT, INTERNATIONAL 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,422 Read SEC document |
| March 11, 2026 Filed Mar 12, 2026 22:10 UTC |
Singh HarvinderEVP & PRESIDENT, INTERNATIONAL
|
Exercise / conversionCommon Stock | 18,922 | $0.00 | $0.00 |
DisclosureSEC source: 0001949782-26-000001 · wk-form4_1773353453.xml · nonDerivative · entry 4 Singh Harvinder · CIK 0001949782 · EVP & PRESIDENT, INTERNATIONAL 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,612 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 11, 2026 Filed Mar 12, 2026 22:10 UTC |
Singh HarvinderEVP & PRESIDENT, INTERNATIONAL
|
Tax withholdingCommon Stock | 861 | $9.61 | $8,274.21 |
DisclosureSEC source: 0001949782-26-000001 · wk-form4_1773353453.xml · nonDerivative · entry 3 Singh Harvinder · CIK 0001949782 · EVP & PRESIDENT, INTERNATIONAL 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,690 Read SEC document |
| March 11, 2026 Filed Mar 12, 2026 21:17 UTC |
DAVIS ROBERT T. JR.EVP & President, TT
|
GrantRestricted Stock Units · Derivative | 43,350 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001563606-26-000001 · wk-form4_1773350251.xml · derivative · entry 3 DAVIS ROBERT T. JR. · CIK 0001563606 · EVP & President, TT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,350 Underlying: Common Stock · 43,350 shares Expires not disclosed F1 · derivative.exercise_date: The award was a restricted stock unit award which will vest 33% on the first and second anniversaries and 34% on the third anniversary of the grant date of 3/11/2026. F1 · derivative.expiration_date: The award was a restricted stock unit award which will vest 33% on the first and second anniversaries and 34% on the third anniversary of the grant date of 3/11/2026. Read SEC document |
| March 11, 2026 Filed Mar 12, 2026 21:17 UTC |
DAVIS ROBERT T. JR.EVP & President, TT
|
Tax withholdingCommon Stock | 8,487 | $9.61 | $81,560.07 |
DisclosureSEC source: 0001563606-26-000001 · wk-form4_1773350251.xml · nonDerivative · entry 2 DAVIS ROBERT T. JR. · CIK 0001563606 · EVP & President, TT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,387 Read SEC document |
| March 11, 2026 Filed Mar 12, 2026 21:18 UTC |
McBreen Michael J.EVP & President, CSS
|
GrantRestricted Stock Units · Derivative | 92,108 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001814943-26-000001 · wk-form4_1773350281.xml · derivative · entry 3 McBreen Michael J. · CIK 0001814943 · EVP & President, CSS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 92,108 Underlying: Common Stock · 92,108 shares Expires not disclosed F1 · derivative.exercise_date: The award was a restricted stock unit award which will vest 33% on the first and second anniversaries and 34% on the third anniversary of the grant date of 3/11/2026. F1 · derivative.expiration_date: The award was a restricted stock unit award which will vest 33% on the first and second anniversaries and 34% on the third anniversary of the grant date of 3/11/2026. Read SEC document |
| March 11, 2026 Filed Mar 12, 2026 21:18 UTC |
McBreen Michael J.EVP & President, CSS
|
Tax withholdingCommon Stock | 7,247 | $9.61 | $69,643.67 |
DisclosureSEC source: 0001814943-26-000001 · wk-form4_1773350281.xml · nonDerivative · entry 2 McBreen Michael J. · CIK 0001814943 · EVP & President, CSS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,743 Read SEC document |
| March 11, 2026 Filed Mar 12, 2026 21:17 UTC |
Mosebrook JeffreySVP, Fin & Princ Acct Officer
|
GrantRestricted Stock Units · Derivative | 15,957 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001719686-26-000001 · wk-form4_1773350218.xml · derivative · entry 3 Mosebrook Jeffrey · CIK 0001719686 · SVP, Fin & Princ Acct Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,957 Underlying: Common Stock · 15,957 shares Expires not disclosed F1 · derivative.exercise_date: The award was a restricted stock unit award which will vest 33% on the first and second anniversaries and 34% on the third anniversary of the grant date of 3/11/2026. F1 · derivative.expiration_date: The award was a restricted stock unit award which will vest 33% on the first and second anniversaries and 34% on the third anniversary of the grant date of 3/11/2026. Read SEC document |
| March 11, 2026 Filed Mar 12, 2026 21:17 UTC |
Mosebrook JeffreySVP, Fin & Princ Acct Officer
|
Tax withholdingCommon Stock | 806 | $9.61 | $7,745.66 |
DisclosureSEC source: 0001719686-26-000001 · wk-form4_1773350218.xml · nonDerivative · entry 2 Mosebrook Jeffrey · CIK 0001719686 · SVP, Fin & Princ Acct Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,453 Read SEC document |
| March 11, 2026 Filed Mar 12, 2026 21:15 UTC |
Veillon-Berteloot ChantalEVP & CHRO
|
GrantRestricted Stock Units · Derivative | 41,783 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001990905-26-000002 · wk-form4_1773350115.xml · derivative · entry 2 Veillon-Berteloot Chantal · CIK 0001990905 · EVP & CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,783 Underlying: Common Stock · 41,783 shares Expires not disclosed F1 · derivative.exercise_date: The award was a restricted stock unit award which will vest 33% on the first and second anniversaries and 34% on the third anniversary of the grant date of 3/11/2026. F1 · derivative.expiration_date: The award was a restricted stock unit award which will vest 33% on the first and second anniversaries and 34% on the third anniversary of the grant date of 3/11/2026. Read SEC document |
| March 11, 2026 Filed Mar 12, 2026 21:15 UTC |
Veillon-Berteloot ChantalEVP & CHRO
|
Tax withholdingCommon Stock | 5,420 | $9.61 | $52,086.20 |
DisclosureSEC source: 0001990905-26-000002 · wk-form4_1773350115.xml · nonDerivative · entry 1 Veillon-Berteloot Chantal · CIK 0001990905 · EVP & CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,227 Read SEC document |
| March 11, 2026 Filed Mar 12, 2026 21:16 UTC |
Knight Lea DanielsEVP & Chief Financial Officer
|
GrantRestricted Stock Units · Derivative | 111,179 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001983748-26-000001 · wk-form4_1773350177.xml · derivative · entry 2 Knight Lea Daniels · CIK 0001983748 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 111,179 Underlying: Common Stock · 111,179 shares Expires not disclosed F1 · derivative.exercise_date: The award was a restricted stock unit award which will vest 33% on the first and second anniversaries and 34% on the third anniversary of the grant date of 3/11/2026. F1 · derivative.expiration_date: The award was a restricted stock unit award which will vest 33% on the first and second anniversaries and 34% on the third anniversary of the grant date of 3/11/2026. Read SEC document |
| March 11, 2026 Filed Mar 12, 2026 21:16 UTC |
Knight Lea DanielsEVP & Chief Financial Officer
|
Tax withholdingCommon Stock | 8,089 | $9.61 | $77,735.29 |
DisclosureSEC source: 0001983748-26-000001 · wk-form4_1773350177.xml · nonDerivative · entry 1 Knight Lea Daniels · CIK 0001983748 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,489 Read SEC document |
| March 11, 2026 Filed Mar 12, 2026 21:07 UTC |
Poul MojdehDirector · President & CEO
|
GrantRestricted Stock Units · Derivative | 343,393 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001743760-26-000003 · wk-form4_1773349619.xml · derivative · entry 1 Poul Mojdeh · CIK 0001743760 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 445,691 Underlying: Common Stock · 343,393 shares Expires not disclosed F1 · derivative.exercise_date: The award was a restricted stock unit award which will vest in three equal annual installments on the first, second and third anniversaries of the grant date of 3/11/2026 and which shall be delivered to Ms. Poul within 30 days following the first business day that occurs immediately following the six month period after the date of her separation of service as deferred compensation. The award is subject to accelerated vesting upon termination of employment by reason of death or disability or upon a qualifying termination on or within 24 months following the date of a change in control. F1 · derivative.expiration_date: The award was a restricted stock unit award which will vest in three equal annual installments on the first, second and third anniversaries of the grant date of 3/11/2026 and which shall be delivered to Ms. Poul within 30 days following the first business day that occurs immediately following the six month period after the date of her separation of service as deferred compensation. The award is subject to accelerated vesting upon termination of employment by reason of death or disability or upon a qualifying termination on or within 24 months following the date of a change in control. Read SEC document |
| March 11, 2026 Filed Mar 12, 2026 21:05 UTC |
Hutchinson Michael DamonEVP, Chief Legal Officer & Sec
|
GrantRestricted Stock Units · Derivative | 70,305 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001606626-26-000004 · wk-form4_1773349536.xml · derivative · entry 1 Hutchinson Michael Damon · CIK 0001606626 · EVP, Chief Legal Officer & Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 159,911 Underlying: Common Stock · 70,305 shares Expires not disclosed F1 · derivative.exercise_date: The award was a restricted stock unit award which will vest 33% on the first and second anniversaries and 34% on the third anniversary of the grant date of 3/11/2026. F1 · derivative.expiration_date: The award was a restricted stock unit award which will vest 33% on the first and second anniversaries and 34% on the third anniversary of the grant date of 3/11/2026. Read SEC document |
| March 10, 2026 Filed Mar 12, 2026 22:10 UTC |
Singh HarvinderEVP & PRESIDENT, INTERNATIONAL
|
Exercise / conversionRestricted Stock Units · Derivative | 1,216 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001949782-26-000001 · wk-form4_1773353453.xml · derivative · entry 6 Singh Harvinder · CIK 0001949782 · EVP & PRESIDENT, INTERNATIONAL 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,350 Underlying: Common Stock · 1,216 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The award was a restricted stock unit award of which 34% vested on the third anniversary of the grant date of 3/10/2023 F1 · derivative.expiration_date: The award was a restricted stock unit award of which 34% vested on the third anniversary of the grant date of 3/10/2023 Read SEC document |
| March 10, 2026 Filed Mar 12, 2026 22:10 UTC |
Singh HarvinderEVP & PRESIDENT, INTERNATIONAL
|
Tax withholdingCommon Stock | 601 | $9.55 | $5,739.55 |
DisclosureSEC source: 0001949782-26-000001 · wk-form4_1773353453.xml · nonDerivative · entry 2 Singh Harvinder · CIK 0001949782 · EVP & PRESIDENT, INTERNATIONAL 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,551 Read SEC document |
| March 10, 2026 Filed Mar 12, 2026 22:10 UTC |
Singh HarvinderEVP & PRESIDENT, INTERNATIONAL
|
Exercise / conversionCommon Stock | 1,216 | $0.00 | $0.00 |
DisclosureSEC source: 0001949782-26-000001 · wk-form4_1773353453.xml · nonDerivative · entry 1 Singh Harvinder · CIK 0001949782 · EVP & PRESIDENT, INTERNATIONAL 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,152 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 10, 2026 Filed Mar 12, 2026 21:17 UTC |
DAVIS ROBERT T. JR.EVP & President, TT
|
Tax withholdingCommon Stock | 687 | $9.55 | $6,560.85 |
DisclosureSEC source: 0001563606-26-000001 · wk-form4_1773350251.xml · nonDerivative · entry 1 DAVIS ROBERT T. JR. · CIK 0001563606 · EVP & President, TT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,874 Read SEC document |
| March 10, 2026 Filed Mar 12, 2026 21:18 UTC |
McBreen Michael J.EVP & President, CSS
|
Tax withholdingCommon Stock | 2,354 | $9.55 | $22,480.70 |
DisclosureSEC source: 0001814943-26-000001 · wk-form4_1773350281.xml · nonDerivative · entry 1 McBreen Michael J. · CIK 0001814943 · EVP & President, CSS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,990 Read SEC document |
| March 10, 2026 Filed Mar 12, 2026 21:17 UTC |
Mosebrook JeffreySVP, Fin & Princ Acct Officer
|
Tax withholdingCommon Stock | 341 | $9.55 | $3,256.55 |
DisclosureSEC source: 0001719686-26-000001 · wk-form4_1773350218.xml · nonDerivative · entry 1 Mosebrook Jeffrey · CIK 0001719686 · SVP, Fin & Princ Acct Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,259 Read SEC document |
| February 02, 2026 Filed Feb 4, 2026 21:24 UTC |
Hutchinson Michael DamonEVP, Chief Legal Officer & Sec
|
GrantRestricted Stock Units · Derivative | 89,606 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001606626-26-000003 · wk-form4_1770240241.xml · derivative · entry 1 Hutchinson Michael Damon · CIK 0001606626 · EVP, Chief Legal Officer & Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 89,606 Underlying: Common Stock · 89,606 shares Expires not disclosed F1 · derivative.exercise_date: The award was a restricted stock unit award which will vest 100% on the second anniversary of the grant date of 02/02/2026. F1 · derivative.expiration_date: The award was a restricted stock unit award which will vest 100% on the second anniversary of the grant date of 02/02/2026. Read SEC document |
| January 06, 2026 Filed Jan 7, 2026 21:10 UTC |
Poul MojdehDirector · President & CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 542 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001743760-26-000002 · wk-form4_1767820207.xml · derivative · entry 6 Poul Mojdeh · CIK 0001743760 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 102,298 Underlying: Common Stock · 542 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The award was a restricted stock unit award which vests in three annual equal installments on the first, second and third anniversaries of the grant date of 1/6/2025 of which the first installment vested on 1/6/2026 and which shall be delivered to Ms. Poul within 30 days following the first business day that occurs immediately following the six-month period after the date of her separation of service as deferred compensation. F1 · derivative.exercise_date: The award was a restricted stock unit award which vests in three annual equal installments on the first, second and third anniversaries of the grant date of 1/6/2025 of which the first installment vested on 1/6/2026 and which shall be delivered to Ms. Poul within 30 days following the first business day that occurs immediately following the six-month period after the date of her separation of service as deferred compensation. F1 · derivative.expiration_date: The award was a restricted stock unit award which vests in three annual equal installments on the first, second and third anniversaries of the grant date of 1/6/2025 of which the first installment vested on 1/6/2026 and which shall be delivered to Ms. Poul within 30 days following the first business day that occurs immediately following the six-month period after the date of her separation of service as deferred compensation. Read SEC document |
| January 06, 2026 Filed Jan 7, 2026 21:10 UTC |
Poul MojdehDirector · President & CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 848 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001743760-26-000002 · wk-form4_1767820207.xml · derivative · entry 5 Poul Mojdeh · CIK 0001743760 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 102,840 Underlying: Common Stock · 848 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The award was a restricted stock unit award which vests in three annual equal installments on the first, second and third anniversaries of the grant date of 1/6/2025 of which the first installment vested on 1/6/2026 and which shall be delivered to Ms. Poul within 30 days following the first business day that occurs immediately following the six-month period after the date of her separation of service as deferred compensation. F1 · derivative.exercise_date: The award was a restricted stock unit award which vests in three annual equal installments on the first, second and third anniversaries of the grant date of 1/6/2025 of which the first installment vested on 1/6/2026 and which shall be delivered to Ms. Poul within 30 days following the first business day that occurs immediately following the six-month period after the date of her separation of service as deferred compensation. F1 · derivative.expiration_date: The award was a restricted stock unit award which vests in three annual equal installments on the first, second and third anniversaries of the grant date of 1/6/2025 of which the first installment vested on 1/6/2026 and which shall be delivered to Ms. Poul within 30 days following the first business day that occurs immediately following the six-month period after the date of her separation of service as deferred compensation. Read SEC document |
| January 06, 2026 Filed Jan 7, 2026 21:10 UTC |
Poul MojdehDirector · President & CEO
|
Tax withholdingCommon Stock | 542 | $13.13 | $7,116.46 |
DisclosureSEC source: 0001743760-26-000002 · wk-form4_1767820207.xml · nonDerivative · entry 4 Poul Mojdeh · CIK 0001743760 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Read SEC document |
| January 06, 2026 Filed Jan 7, 2026 21:10 UTC |
Poul MojdehDirector · President & CEO
|
Tax withholdingCommon Stock | 848 | $13.13 | $11,134.24 |
DisclosureSEC source: 0001743760-26-000002 · wk-form4_1767820207.xml · nonDerivative · entry 3 Poul Mojdeh · CIK 0001743760 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 542 Read SEC document |
| January 06, 2026 Filed Jan 7, 2026 21:10 UTC |
Poul MojdehDirector · President & CEO
|
Exercise / conversionCommon Stock | 542 | $0.00 | $0.00 |
DisclosureSEC source: 0001743760-26-000002 · wk-form4_1767820207.xml · nonDerivative · entry 2 Poul Mojdeh · CIK 0001743760 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,390 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 06, 2026 Filed Jan 7, 2026 21:10 UTC |
Poul MojdehDirector · President & CEO
|
Exercise / conversionCommon Stock | 848 | $0.00 | $0.00 |
DisclosureSEC source: 0001743760-26-000002 · wk-form4_1767820207.xml · nonDerivative · entry 1 Poul Mojdeh · CIK 0001743760 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 848 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 05, 2025 Filed Nov 6, 2025 21:05 UTC |
GRAVES JEFFREY ADirector
|
PurchaseCommon Stock | 9,000 | $11.35 | $102,150.00 |
DisclosureSEC source: 0001251036-25-000006 · wk-form4_1762463143.xml · nonDerivative · entry 1 GRAVES JEFFREY A · CIK 0001251036 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,086 Read SEC document |
| October 12, 2025 Filed Oct 14, 2025 20:28 UTC |
Singh HarvinderEVP & PRESIDENT, INTERNATIONAL
|
Exercise / conversionRestricted Stock Units · Derivative | 11,965 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001949782-25-000003 · wk-form4_1760473706.xml · derivative · entry 3 Singh Harvinder · CIK 0001949782 · EVP & PRESIDENT, INTERNATIONAL 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,566 Underlying: Common Stock · 11,965 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The award was a restricted stock unit award which vested in full on the third anniversary of the grant date of 10/12/2022. F2 · derivative.expiration_date: The award was a restricted stock unit award which vested in full on the third anniversary of the grant date of 10/12/2022. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.